STILWELL, Kan. - The Boston Marathon is the best-known and most sought-after marathon for devoted runners throughout the world. One metro man just finished the 26.2 mile challenge, and while he didn't come in first place for speed, his accomplishment is one that deserves a medal of its own.
At the 25th mile marker, Jim Weber looked a lot like most exhausted runners in the final wave of the Boston Marathon. The embrace shared between Jim and his wife, however, means more than nearing the end of a 26 mile journey.
"This has been a year-long journey going from diagnosis to where we're at today," said Weber, pointing to his race medal.
More than a year ago, Jim Weber was diagnosed with Multiple Myeloma-
"Ninety-five percent of my bone marrow was cancerous plasma," said Weber.
He wouldn't have known he was sick if he wasn't training for his very first marathon at the age of 49.
"I started training. I was up to 10, 12 miles, and all of a sudden, I couldn't run half a mile," said Weber.
The diagnosis marked the end of Weber's dreams for a marathon in 2015, but he knew he'd run in 2016.
"Being physically active when you have cancer to me was the most important thing," Weber said.
Weber decided he'd run the Boston Marathon in 2016 to raise money for the Multiple Myeloma Research Foundation, or MMRF. The team wasn't so sure he'd really be ready.
After months of chemo and transplants, Weber was in remission, and he was taking steps to find a cure.
"You have a choice every day when you wake up- you can wake up with a smile, or you can wake up mad at the world," said Weber.
Weber started asking friends to donate to MMRF, and in exchange he'd run 26.2 miles, while still undergoing chemo treatments every two weeks.
"You want to lay in bed, there are days you don't want to get up. But it's so critical to stay active," Weber said. "It's worth it. It's been worth every sweat- every ounce of sweat that I've put out trying to get ready for this thing. I'm glad to be supporting that group."
To support Jim’s effort to raise $225,000; click here.